- Pharma Giants’ $454M Glumetza Antitrust Deal Gets Initial OK
- Lupin agrees to pay $150 mln to settle Glumetza antitrust claims
- Bausch to pay $300 mln in antitrust suit over diabetes drug
- Mexico is suing US gunmakers for thousands of guns trafficked across the border each year. Can they win?
- Takeda Can’t Duck Generic-Drug Delay Suit at 2nd Circ.